Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors

Completed

• Conditions: Quality of Life; Chemeotherapy; Immunotherapy; Treatment Mofidied; Coronavirus

• Registration Number: NCT04389684
• Lead Sponsor: Poitiers University Hospital

Brief Summary

To limit Corona virus dissemination on its territory, France applied strict confinement from March 16th to May 11th. Scientific societies recommended treatment modifications and remote consultations that were applied. This study evaluates the clinical impact of these care adaptation on patients under treatment for a digestive tumor. A special focus is made on quality of life and psycho-social impact of treatment modifications on patients diagnosed with metastatic colorectal cancer and metastatic pancreatic cancer.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-05-14
• Study First Submitted QC: 2020-05-14
• Study First Posted: 2020-05-15
• Study Start: 2020-05-27
• Primary Completion: 2020-11-20
• Study Completion: 2020-11-20
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-26
• Last Update Posted: 2021-11-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 102

Inclusion Criteria

• Histologically proven digestive tumor
• Ongoing treatment from March,1st and April 30th

Exclusion Criteria

• Patient refusal for enrollment in the study
• Patient not recognised legally competent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival of patients with metastatic colorectal cancer or metastatic pancreatic cancer	6 months

Trial Locations

Locations (3)

MOULIN Valérie; 🇫🇷 La Rochelle, France

RANDRIAN Violaine; 🇫🇷 Poitiers, France

BOURGEOIS Hugues; 🇫🇷 Le Mans, France